🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of next-day British shipping. Vendors market the substance there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Digital Trading Activities

Research also found communities with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of joining one community, a vendor posted contact information, where the majority of transactions take place. The vendor sent an guidebook and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, health issues or past usage.

Product Information and Pricing

Within these groups, posts display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has previously seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to potentially significant medical dangers”.